Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Feasibility and acceptability of using an Interactive Voice Response System (IVRS) to assess decision making about sun protection.

Holland SM, Shuk E, Burkhalter J, Shouery M, Li Y, Hay JL.

Psychooncology. 2019 Sep 13. doi: 10.1002/pon.5231. [Epub ahead of print]

PMID:
31520426
2.

Using NCI-designated Cancer Center Catchment Area data to understand an ignored but high need constituent: People uncertain or avoidant about their cancer risk.

Hay JL, Kiviniemi MT, Orom H, Waters EA.

Cancer Epidemiol Biomarkers Prev. 2019 Sep 9. pii: cebp.0430.2019. doi: 10.1158/1055-9965.EPI-19-0430. [Epub ahead of print]

PMID:
31501151
3.

MC1R Variation in a New Mexico Population.

White KAM, Dailey YT, Guest DD, Zielaskowski K, Robers E, Sussman A, Hunley K, Hughes CR, Schwartz MR, Kaphingst KA, Buller DB, Hay JL, Berwick M.

Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: cebp.0378.2019. doi: 10.1158/1055-9965.EPI-19-0378. [Epub ahead of print]

PMID:
31488411
4.

Psychosocial and Cultural Determinants of Interest and Uptake of Skin Cancer Genetic Testing in Diverse Primary Care.

Hay JL, Meyer White K, Sussman A, Kaphingst K, Guest D, Schofield E, Dailey YT, Robers E, Schwartz MR, Zielaskowski K, Li Y, Buller D, Hunley K, Berwick M.

Public Health Genomics. 2019;22(1-2):58-68. doi: 10.1159/000501985. Epub 2019 Aug 22.

5.

Lay beliefs about risk: relation to risk behaviors and to probabilistic risk perceptions.

Riley KE, Hay JL, Waters EA, Biddle C, Schofield E, Li Y, Orom H, Kiviniemi MT.

J Behav Med. 2019 May 15. doi: 10.1007/s10865-019-00036-1. [Epub ahead of print]

PMID:
31093806
6.

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans.

van Amerongen G, Siebenga PS, Gurrell R, Dua P, Whitlock M, Gorman D, Okkerse P, Hay JL, Butt RP, Groeneveld GJ.

Br J Anaesth. 2019 Aug;123(2):e194-e203. doi: 10.1016/j.bja.2018.12.006. Epub 2019 Jan 31.

7.

The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia.

Ali S, Dunmore HM, Karres D, Hay JL, Salmonsson T, Gisselbrecht C, Sarac SB, Bjerrum OW, Hovgaard D, Barbachano Y, Nagercoil N, Pignatti F.

Oncologist. 2019 May;24(5):e171-e179. doi: 10.1634/theoncologist.2019-0025. Epub 2019 Mar 21.

PMID:
30898889
8.

Parent and child perspectives on perceived barriers to child sun protection and their association with sun protection strategies among children of melanoma survivors.

Wu YP, Parsons BG, Aspinwall LG, Hay JL, Boucher KM, Caputo H, Mooney R, Grossman D, Leachman SA.

Pediatr Dermatol. 2019 May;36(3):317-323. doi: 10.1111/pde.13796. Epub 2019 Mar 20.

PMID:
30895676
9.

Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs.

Siebenga PS, van Amerongen G, Okkerse P, Denney WS, Dua P, Butt RP, Hay JL, Groeneveld GJ.

Eur J Pain. 2019 Jul;23(6):1129-1140. doi: 10.1002/ejp.1379. Epub 2019 Apr 5.

10.

Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control.

Parsons BG, Hay JL, Aspinwall LG, Zaugg K, Zhu A, Mooney RH, Klein SZ, Grossman D, Leachman SA, Wu YP.

J Cancer Educ. 2019 Feb 15. doi: 10.1007/s13187-019-01489-3. [Epub ahead of print]

PMID:
30771212
11.

"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering.

Hamilton JG, Genoff Garzon M, Westerman JS, Shuk E, Hay JL, Walters C, Elkin E, Bertelsen C, Cho J, Daly B, Gucalp A, Seidman AD, Zauderer MG, Epstein AS, Kris MG.

J Oncol Pract. 2019 Apr;15(4):e277-e288. doi: 10.1200/JOP.18.00417. Epub 2019 Jan 28.

PMID:
30689492
12.

Standardization of the Fried frailty phenotype improves cardiovascular disease risk discrimination.

Boreskie KF, Kehler DS, Costa EC, Hiebert BM, Hamm NC, Moffatt TL, Hay JL, Stammers AN, Kimber DE, Kent DE, Cornish DE, Arora RC, Strachan SM, Semenchuk BN, Duhamel TA.

Exp Gerontol. 2019 May;119:40-44. doi: 10.1016/j.exger.2019.01.021. Epub 2019 Jan 23.

PMID:
30682391
13.

Pre-Operative Frailty Status Is Associated with Cardiac Rehabilitation Completion: A Retrospective Cohort Study.

Kimber DE, Kehler DS, Lytwyn J, Boreskie KF, Jung P, Alexander B, Hiebert BM, Dubiel C, Hamm NC, Stammers AN, Clarke M, Fraser C, Pedreira B, Tangri N, Hay JL, Arora RC, Duhamel TA.

J Clin Med. 2018 Dec 17;7(12). pii: E560. doi: 10.3390/jcm7120560.

14.

Differences in Rural and Urban Health Information Access and Use.

Chen X, Orom H, Hay JL, Waters EA, Schofield E, Li Y, Kiviniemi MT.

J Rural Health. 2019 Jun;35(3):405-417. doi: 10.1111/jrh.12335. Epub 2018 Nov 16.

PMID:
30444935
15.

Low Health Literacy and Health Information Avoidance but Not Satisficing Help Explain "Don't Know" Responses to Questions Assessing Perceived Risk.

Orom H, Schofield E, Kiviniemi MT, Waters EA, Biddle C, Chen X, Li Y, Kaphingst KA, Hay JL.

Med Decis Making. 2018 Nov;38(8):1006-1017. doi: 10.1177/0272989X18799999.

PMID:
30403579
16.

Vigorous Intervals and Hypoglycemia in Type 1 Diabetes: A Randomized Cross Over Trial.

Rempel M, Yardley JE, MacIntosh A, Hay JL, Bouchard D, Cornish S, Marks SD, Hai Y, Gordon JW, McGavock J.

Sci Rep. 2018 Oct 26;8(1):15879. doi: 10.1038/s41598-018-34342-6.

17.

A systematic review of the association between sedentary behaviors with frailty.

Kehler DS, Hay JL, Stammers AN, Hamm NC, Kimber DE, Schultz ASH, Szwajcer A, Arora RC, Tangri N, Duhamel TA.

Exp Gerontol. 2018 Dec;114:1-12. doi: 10.1016/j.exger.2018.10.010. Epub 2018 Oct 22.

PMID:
30355522
18.

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3. Review. Erratum in: Cancer. 2019 Aug 1;125(15):2706.

PMID:
30281145
19.

Barriers to physical activity: a study of academic and community cancer survivors with pain.

Romero SAD, Brown JC, Bauml JM, Hay JL, Li QS, Cohen RB, Mao JJ.

J Cancer Surviv. 2018 Dec;12(6):744-752. doi: 10.1007/s11764-018-0711-y. Epub 2018 Sep 4.

PMID:
30182150
20.

Health Literacy and Use and Trust in Health Information.

Chen X, Hay JL, Waters EA, Kiviniemi MT, Biddle C, Schofield E, Li Y, Kaphingst K, Orom H.

J Health Commun. 2018;23(8):724-734. doi: 10.1080/10810730.2018.1511658. Epub 2018 Aug 30.

21.

Examining the Interrelations Among Objective and Subjective Health Literacy and Numeracy and Their Associations with Health Knowledge.

Waters EA, Biddle C, Kaphingst KA, Schofield E, Kiviniemi MT, Orom H, Li Y, Hay JL.

J Gen Intern Med. 2018 Nov;33(11):1945-1953. doi: 10.1007/s11606-018-4624-2. Epub 2018 Aug 17.

PMID:
30120636
22.

Exercise in Pregnancy and Children's Cardiometabolic Risk Factors: a Systematic Review and Meta-Analysis.

Guillemette L, Hay JL, Kehler DS, Hamm NC, Oldfield C, McGavock JM, Duhamel TA.

Sports Med Open. 2018 Aug 2;4(1):35. doi: 10.1186/s40798-018-0148-x. Review.

23.

Effects of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training On Blood Pressure in Adults with Pre- to Established Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials.

Costa EC, Hay JL, Kehler DS, Boreskie KF, Arora RC, Umpierre D, Szwajcer A, Duhamel TA.

Sports Med. 2018 Sep;48(9):2127-2142. doi: 10.1007/s40279-018-0944-y. Review.

PMID:
29949110
24.

Prevalence and Correlates of Worry About Medical Imaging Radiation Among United States Cancer Survivors.

Hay JL, Baser RE, Westerman JS, Ford JS.

Int J Behav Med. 2018 Oct;25(5):569-578. doi: 10.1007/s12529-018-9730-3.

PMID:
29872990
25.

Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Hay JL, Zielaskowski K, Meyer White K, Kaphingst K, Robers E, Guest D, Sussman A, Talamantes Y, Schwartz M, Rodríguez VM, Li Y, Schofield E, Bigney J, Hunley K, Buller D, Berwick M.

JAMA Dermatol. 2018 Jun 1;154(6):684-693. doi: 10.1001/jamadermatol.2018.0592.

26.

Trending on Pinterest: an examination of pins about skin tanning.

Banerjee SC, Rodríguez VM, Greene K, Hay JL.

Transl Behav Med. 2018 Apr 10. doi: 10.1093/tbm/iby036. [Epub ahead of print]

27.

Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects.

van Amerongen G, Siebenga P, de Kam ML, Hay JL, Groeneveld GJ.

Eur J Pain. 2018 Aug;22(7):1331-1342. doi: 10.1002/ejp.1222. Epub 2018 Apr 25.

PMID:
29635857
28.

Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children.

Wu YP, Parsons BG, Mooney R, Aspinwall LG, Cloyes K, Hay JL, Kohlmann W, Grossman D, Leachman SA.

J Community Health. 2018 Oct;43(5):993-1001. doi: 10.1007/s10900-018-0516-y.

PMID:
29623503
29.

The association between bouts of moderate to vigorous physical activity and patterns of sedentary behavior with frailty.

Kehler DS, Clara I, Hiebert B, Stammers AN, Hay JL, Schultz A, Arora RC, Tangri N, Duhamel TA.

Exp Gerontol. 2018 Apr;104:28-34. doi: 10.1016/j.exger.2018.01.014. Epub 2018 Feb 3.

PMID:
29421349
30.

Education-based disparities in knowledge of novel health risks: The case of knowledge gaps in HIV risk perceptions.

Kiviniemi MT, Orom H, Waters EA, McKillip M, Hay JL.

Br J Health Psychol. 2018 May;23(2):420-435. doi: 10.1111/bjhp.12297. Epub 2018 Jan 31.

31.

Marshaling the Translational Potential of MC1R for Precision Risk Assessment of Melanoma.

Kanetsky PA, Hay JL.

Cancer Prev Res (Phila). 2018 Mar;11(3):121-124. doi: 10.1158/1940-6207.CAPR-17-0255. Epub 2017 Dec 15.

32.

Causes and consequences of uncertainty about illness risk perceptions.

Orom H, Biddle C, Waters EA, Kiviniemi MT, Sosnowski AN, Hay JL.

J Health Psychol. 2017 Dec 1:1359105317745966. doi: 10.1177/1359105317745966. [Epub ahead of print]

33.

Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models.

Loudon P, Siebenga P, Gorman D, Gore K, Dua P, van Amerongen G, Hay JL, Groeneveld GJ, Butt RP.

Br J Clin Pharmacol. 2018 Feb;84(2):301-309. doi: 10.1111/bcp.13448. Epub 2017 Nov 28.

34.

What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales.

Atkinson TM, Hay JL, Dueck AC, Mitchell SA, Mendoza TR, Rogak LJ, Minasian LM, Basch E.

J Pain Symptom Manage. 2018 Mar;55(3):e3-e6. doi: 10.1016/j.jpainsymman.2017.10.024. Epub 2017 Nov 10. No abstract available.

35.

Interdisciplinary Perspectives on Sun Safety.

Geller AC, Jablonski NG, Pagoto SL, Hay JL, Hillhouse J, Buller DB, Kenney WL, Robinson JK, Weller RB, Moreno MA, Gilchrest BA, Sinclair C, Arndt J, Taber JM, Morris KL, Dwyer LA, Perna FM, Klein WMP, Suls J.

JAMA Dermatol. 2018 Jan 1;154(1):88-92. doi: 10.1001/jamadermatol.2017.4201. Review.

36.

Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study.

Boreskie KF, Kehler DS, Costa EC, Cortez PC, Berkowitz I, Hamm NC, Moffatt TL, Stammers AN, Kimber DE, Hiebert BM, Kent DE, Cornish DE, Blewett H, Nguyen T, Arora RC, Strachan SM, Semenchuk BN, Hay JL, Cohn JN, Duhamel TA.

BMJ Open. 2017 Nov 3;7(11):e018249. doi: 10.1136/bmjopen-2017-018249.

37.

Real-time sun protection decisions in first-degree relatives of melanoma patients.

Hay JL, Shuk E, Schofield E, Loeb R, Holland S, Burkhalter J, Li Y.

Health Psychol. 2017 Sep;36(9):907-915. doi: 10.1037/hea0000523.

38.

Measurement invariance of intuitive cancer risk perceptions across diverse populations: The Cognitive Causation and Negative Affect in Risk scales.

Baser RE, Li Y, Brennessel D, Kemeny MM, Hay JL.

J Health Psychol. 2019 Aug;24(9):1221-1232. doi: 10.1177/1359105317693910. Epub 2017 Feb 1.

PMID:
28810422
39.

Tanning and Teens: Is Indoor Exposure the Tip of the Iceberg?

Hay JL, Riley KE, Geller AC.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1170-1174. doi: 10.1158/1055-9965.EPI-17-0095.

40.

Commentary on the MID3 Good Practices Paper.

Manolis E, Brogren J, Cole S, Hay JL, Nordmark A, Karlsson KE, Lentz F, Benda N, Wangorsch G, Pons G, Zhao W, Gigante V, Serone F, Standing JF, Dokoumetzidis A, Vakkilainen J, van den Heuvel M, Mangas Sanjuan V, Taminiau J, Kerwash E, Khan D, Musuamba FT, Skottheim Rusten I; EMA Modelling and Simulation Working Group.

CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):416-417. doi: 10.1002/psp4.12223. Epub 2017 Jul 22.

41.

Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.

Hamilton JG, Shuk E, Genoff MC, Rodríguez VM, Hay JL, Offit K, Robson ME.

J Oncol Pract. 2017 Jul;13(7):e590-e601. doi: 10.1200/JOP.2016.020057. Epub 2017 Jun 19.

42.

Recognizing Latinos' range of skin pigment and phototypes to enhance skin cancer prevention.

Robinson JK, Penedo FJ, Hay JL, Jablonski NG.

Pigment Cell Melanoma Res. 2017 Sep;30(5):488-492. doi: 10.1111/pcmr.12598. Epub 2017 Jul 4.

43.

Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.

Hay JL, Berwick M, Zielaskowski K, White KA, Rodríguez VM, Robers E, Guest DD, Sussman A, Talamantes Y, Schwartz MR, Greb J, Bigney J, Kaphingst KA, Hunley K, Buller DB.

JMIR Res Protoc. 2017 Apr 25;6(4):e52. doi: 10.2196/resprot.7158.

44.

All in the family? Communication of cancer survivors with their families.

Bowen DJ, Hay JL, Harris-Wai JN, Meischke H, Burke W.

Fam Cancer. 2017 Oct;16(4):597-603. doi: 10.1007/s10689-017-9987-8.

45.

Patient perspectives on ipilimumab across the melanoma treatment trajectory.

Shuk E, Shoushtari AN, Luke J, Postow MA, Callahan M, Harding JJ, Roth KG, Flavin M, Granobles A, Christian J, Gold G, Schoenhammer M, Gordon M, Cimaglia N, Dyson R, Goodman-Davis N, Colgan MN, Jefferson IS, Munhoz R, D'Angelo S, Wolchok J, Chapman P, Chi P, Carvajal RD, Hay JL.

Support Care Cancer. 2017 Jul;25(7):2155-2167. doi: 10.1007/s00520-017-3621-z. Epub 2017 Mar 1.

46.

Friendly tanning: young adults' engagement with friends around indoor tanning.

Rodríguez VM, Daniel CL, Welles BF, Geller AC, Hay JL.

J Behav Med. 2017 Aug;40(4):631-640. doi: 10.1007/s10865-017-9832-4. Epub 2017 Feb 8.

47.

Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.

Hamilton JG, Genoff MC, Salerno M, Amoroso K, Boyar SR, Sheehan M, Fleischut MH, Siegel B, Arnold AG, Salo-Mullen EE, Hay JL, Offit K, Robson ME.

Breast Cancer Res Treat. 2017 Apr;162(2):297-306. doi: 10.1007/s10549-017-4123-x. Epub 2017 Feb 1.

48.

The urgent need to ban youth indoor tanning: evidence from college undergraduates.

Daniel CL, Hay JL, Welles BF, Geller AC.

Transl Behav Med. 2017 Dec;7(4):645-647. doi: 10.1007/s13142-017-0469-1. No abstract available.

49.

Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties.

Okkerse P, Hay JL, Sitsen E, Dahan A, Klaassen E, Houghton W, Groeneveld GJ.

Br J Clin Pharmacol. 2017 Apr;83(4):751-763. doi: 10.1111/bcp.13176. Epub 2016 Dec 16.

50.

Measuring blood-brain barrier penetration using the NeuroCart, a CNS test battery.

Groeneveld GJ, Hay JL, Van Gerven JM.

Drug Discov Today Technol. 2016 Jun;20:27-34. doi: 10.1016/j.ddtec.2016.07.004. Epub 2016 Oct 21. Review.

Supplemental Content

Support Center